ALMS

Alumis Inc
NASDAQHEALTHCAREBIOTECHNOLOGY

Key Statistics

Market Cap
$2.81B
P/E Ratio
EPS
$-1.78
Beta
52W High
$30.60
52W Low
$2.76
50-Day MA
$23.94
200-Day MA
$15.10
Dividend Yield
Profit Margin
0.00%
Forward P/E
PEG Ratio

About Alumis Inc

Alumis Inc. (ALMS) stands at the forefront of the aluminum industry, specializing in the development and commercialization of high-performance aluminum products tailored for essential sectors, including automotive, aerospace, and construction. Through its proprietary technologies and a steadfast commitment to sustainable manufacturing, Alumis not only advances material science but also emphasizes environmental responsibility. The company's robust focus on research and development positions it to effectively seize emerging market opportunities, with a diverse product portfolio designed to meet evolving client needs. With a dedication to operational excellence and sustainable practices, Alumis is strategically poised for long-term growth and value creation for its stakeholders.

Official WebsiteUSAFY End: December

Fundamentals

Revenue (TTM)$8.40M
Gross Profit (TTM)$8.40M
EBITDA$-435.26M
Operating Margin-5652.00%
Return on Equity-64.60%
Return on Assets-58.80%
Revenue/Share (TTM)$0.08
Book Value$4.46
Price-to-Book4.96
Price-to-Sales (TTM)334.13
EV/Revenue276.44
EV/EBITDA
Quarterly Earnings Growth (YoY)0.00%
Quarterly Revenue Growth (YoY)-90.00%
Shares Outstanding$123.43M
Float$85.87M
% Insiders0.61%
% Institutions99.68%

Historical Volatility

HV 10-Day
65.42%
HV 20-Day
64.34%
HV 30-Day
59.01%
HV 60-Day
74.83%
HV Rank

Volatility is currently expanding

Analyst Ratings

Consensus ($40.10 target)
1
Strong Buy
10
Buy

More HEALTHCARE Stocks

Data last updated: 5/25/2026